Eddit
Zeile 2: | Zeile 2: | ||
*'''[[Further reading]]''' | *'''[[Further reading]]''' | ||
{{tp|p=32362782|t=2020. Aktuelle Informationen zu COVID-19 auf einer Plattform ? zeitschriftenübergreifend |pdf=|usr=}} | {{tp|p=32362782|t=2020. Aktuelle Informationen zu COVID-19 auf einer Plattform ? zeitschriftenübergreifend |pdf=|usr=}} | ||
− | + | *[https://www.gisaid.org/ GISAID database on covid19] | |
*'''[[Unproven ideas]]''' | *'''[[Unproven ideas]]''' | ||
Zeile 11: | Zeile 11: | ||
{{tp|p=32334862|t=ä. COVID-19�: caract�ristiques cliniques, biologiques et radiologiques chez l?adulte, la femme enceinte et l?enfant Une mise au point au c?ur de la pand�mie |pdf=|usr=}} | {{tp|p=32334862|t=ä. COVID-19�: caract�ristiques cliniques, biologiques et radiologiques chez l?adulte, la femme enceinte et l?enfant Une mise au point au c?ur de la pand�mie |pdf=|usr=}} | ||
{{tp|p=32336927|t=ä. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Emergence, History, Basic and Clinical Aspects |pdf=|usr=}} | {{tp|p=32336927|t=ä. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Emergence, History, Basic and Clinical Aspects |pdf=|usr=}} | ||
− | + | {{tp|p=32371230|t=2020. Evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) as coronavirus disease 2019 (COVID-19) pandemic: A global health emergency |pdf=|usr=}} | |
− | + | {{tp|p=32344226|t=2020. COVID-19: Disease, management, treatment, and social impact |pdf=|usr=}} | |
*'''[[Clinical guidelines and advice]]''' | *'''[[Clinical guidelines and advice]]''' | ||
Zeile 44: | Zeile 44: | ||
{{tp|p=32269081|t=2020. Phylogenetic network analysis of SARS-CoV-2 genomes |pdf=|usr=}} | {{tp|p=32269081|t=2020. Phylogenetic network analysis of SARS-CoV-2 genomes |pdf=|usr=}} | ||
{{tp|p=32009228|t=2020. Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission |pdf=|usr=}} | {{tp|p=32009228|t=2020. Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission |pdf=|usr=}} | ||
+ | {{tp|p=32277040|t=2020. Structure of the RNA-dependent RNA polymerase from COVID-19 virus |pdf=|usr=}} | ||
+ | {{tp|p=32075877|t=2020. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation |pdf=|usr=}} | ||
+ | |||
*'''[[Target binding and uptake]]''' | *'''[[Target binding and uptake]]''' | ||
{{tp|p=32165541|t=2020. Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells |pdf=|usr=}} | {{tp|p=32165541|t=2020. Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells |pdf=|usr=}} | ||
{{tp|p=32364961|t=2020. Severe respiratory SARS-CoV2 infection: Does ACE2 receptor matter?|pdf=|usr=}} | {{tp|p=32364961|t=2020. Severe respiratory SARS-CoV2 infection: Does ACE2 receptor matter?|pdf=|usr=}} | ||
− | + | {{tp|p=32245784|t=2020. A highly conserved cryptic epitope in the receptor binding domains of SARS-CoV-2 and SARS-CoV |pdf=|usr=}} | |
+ | {{tp|p=32366695|t=ä. Site-specific glycan analysis of the SARS-CoV-2 spike |pdf=|usr=}} | ||
+ | {{tp|p=32132184|t=2020. Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2 |pdf=|usr=}} | ||
*'''[[Cytopathic effects]]''' | *'''[[Cytopathic effects]]''' | ||
Zeile 74: | Zeile 79: | ||
*'''[[Disease Models]]''' | *'''[[Disease Models]]''' | ||
{{tp|p=32303993|t=ä. Recapitulation of SARS-CoV-2 infection and cholangiocyte damage with human liver ductal organoids |pdf=|usr=}} | {{tp|p=32303993|t=ä. Recapitulation of SARS-CoV-2 infection and cholangiocyte damage with human liver ductal organoids |pdf=|usr=}} | ||
− | + | {{tp|p=32303590|t=2020. Comparative pathogenesis of COVID-19, MERS, and SARS in a nonhuman primate model |pdf=|usr=}} | |
*'''[[Similar diseases and pathomechanisms]]''' | *'''[[Similar diseases and pathomechanisms]]''' | ||
Zeile 119: | Zeile 124: | ||
{{tp|p=32334841|t=ä. COVID-19 may induce Guillain-Barr� syndrome |pdf=|usr=}} | {{tp|p=32334841|t=ä. COVID-19 may induce Guillain-Barr� syndrome |pdf=|usr=}} | ||
{{tp|p=32246403|t=ä. The brain, another potential target organ, needs early protection from SARS-CoV-2 neuroinvasion |pdf=|usr=}} | {{tp|p=32246403|t=ä. The brain, another potential target organ, needs early protection from SARS-CoV-2 neuroinvasion |pdf=|usr=}} | ||
− | + | {{tp|p=32344366|t=2020. Focal status epilepticus as unique clinical feature of COVID-19: A case report |pdf=|usr=}} | |
*'''[[Dermatology]]''' | *'''[[Dermatology]]''' | ||
Zeile 130: | Zeile 135: | ||
{{tp|p=32343593|t=2020. COVID-19, coronavirus, SARS-CoV-2 and the small bowel |pdf=|usr=}} | {{tp|p=32343593|t=2020. COVID-19, coronavirus, SARS-CoV-2 and the small bowel |pdf=|usr=}} | ||
{{tp|p=32376072|t=ä. Beware: Gastrointestinal symptoms can be a manifestation of COVID-19 |pdf=|usr=}} | {{tp|p=32376072|t=ä. Beware: Gastrointestinal symptoms can be a manifestation of COVID-19 |pdf=|usr=}} | ||
+ | {{tp|p=32353720|t=2020. COVID-19 faecal-oral transmission: Are we asking the right questions?|pdf=|usr=}} | ||
+ | {{tp|p=32358202|t=ä. SARS-CoV-2 productively infects human gut enterocytes |pdf=|usr=}} | ||
+ | |||
Zeile 142: | Zeile 150: | ||
{{tp|p=32314010|t=ä. Coronavirus Disease 19 (COVID-19) complicated with pneumonia in a patient with rheumatoid arthritis receiving conventional disease-modifying antirheumatic drugs |pdf=|usr=}} | {{tp|p=32314010|t=ä. Coronavirus Disease 19 (COVID-19) complicated with pneumonia in a patient with rheumatoid arthritis receiving conventional disease-modifying antirheumatic drugs |pdf=|usr=}} | ||
{{tp|p=32346493|t=ä. Clinical presentations and outcomes of SARS-CoV-2 infected pneumonia in pregnant women and health status of their neonates |pdf=|usr=}} | {{tp|p=32346493|t=ä. Clinical presentations and outcomes of SARS-CoV-2 infected pneumonia in pregnant women and health status of their neonates |pdf=|usr=}} | ||
+ | {{tp|p=32335406|t=ä. Factors associated with negative conversion of viral RNA in patients hospitalized with COVID-19 |pdf=|usr=}} | ||
+ | |||
*'''[[The morbid survivor]]''' | *'''[[The morbid survivor]]''' | ||
+ | {{tp|p=32360909|t=ä. Follow-up studies in COVID-19 recovered patients - is it mandatory?|pdf=|usr=}} | ||
+ | |||
*'''[[Case reports]]''' | *'''[[Case reports]]''' | ||
Zeile 163: | Zeile 175: | ||
{{tp|p=32232552|t=ä. Coronavirus disease 2019 (COVID-19) and anti-rheumatic drugs |pdf=|usr=}} | {{tp|p=32232552|t=ä. Coronavirus disease 2019 (COVID-19) and anti-rheumatic drugs |pdf=|usr=}} | ||
{{tp|p=32124179|t=ä. Clinical trials for the treatment of Coronavirus disease 2019 (COVID-19): A rapid response to urgent need |pdf=|usr=}} | {{tp|p=32124179|t=ä. Clinical trials for the treatment of Coronavirus disease 2019 (COVID-19): A rapid response to urgent need |pdf=|usr=}} | ||
+ | {{tp|p=32376987|t=2020. Inhibition of Influenza A virus propagation by benzoselenoxanthenes stabilizing TMPRSS2 Gene G-quadruplex and hence down-regulating TMPRSS2 expression |pdf=|usr=}} | ||
+ | {{tp|p=32278175|t=ä. COVID-19: A promising cure for the global panic |pdf=|usr=}} | ||
+ | {{tp|p=32253226|t=ä. (β-D-N4-hydroxycytidine (NHC, EIDD-1931) An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice |pdf=|usr=}} | ||
+ | {{tp|p=32358203|t=ä. Structural basis for inhibition of the RNA-dependent RNA polymerase from SARS-CoV-2 by remdesivir |pdf=|usr=}} | ||
+ | {{tp|p=32198291|t=2020. Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved ?-ketoamide inhibitors |pdf=|usr=}} | ||
+ | {{tp|p=32321856|t=ä. Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease |pdf=|usr=}} | ||
+ | |||
Zeile 174: | Zeile 193: | ||
*'''[[Passive protective equipment]]''' | *'''[[Passive protective equipment]]''' | ||
+ | {{ttp|p=32322159|t=ä. Electrostatic Charged Nanofiber Filter for Filtering Airborne Novel Coronavirus (COVID-19) and Nano-aerosols |pdf=|usr=}} | ||
+ | {{ttp|p=32372877|t=2020. Charged PVDF multilayer nanofiber filter in filtering simulated airborne novel coronavirus (COVID-19) using ambient nano-aerosols |pdf=|usr=}} | ||
Zeile 194: | Zeile 215: | ||
{{tp|p=32299718|t=ä. Ecosystem approaches to the risk for schizophrenia |pdf=|usr=}} | {{tp|p=32299718|t=ä. Ecosystem approaches to the risk for schizophrenia |pdf=|usr=}} | ||
{{tp|p=32327314|t=ä. COVID-19, mobile health and serious mental illness |pdf=|usr=}} | {{tp|p=32327314|t=ä. COVID-19, mobile health and serious mental illness |pdf=|usr=}} | ||
− | + | {{tp|p=32370129|t=2020. Blockchain-Based Healthcare Workflow for Tele-Medical Laboratory in Federated Hospital IoT Clouds |pdf=|usr=}} | |
Zeile 221: | Zeile 242: | ||
{{tp|p=32313382|t=ä. Can Global Pharmaceutical Supply Chains Scale Up Sustainably for the COVID-19 Crisis?|pdf=|usr=}} | {{tp|p=32313382|t=ä. Can Global Pharmaceutical Supply Chains Scale Up Sustainably for the COVID-19 Crisis?|pdf=|usr=}} | ||
{{tp|p=32313383|t=2020. A brave new world: Lessons from the COVID-19 pandemic for transitioning to sustainable supply and production |pdf=|usr=}} | {{tp|p=32313383|t=2020. A brave new world: Lessons from the COVID-19 pandemic for transitioning to sustainable supply and production |pdf=|usr=}} | ||
+ | {{tp|p=32304970|t=2020. Challenges and solutions for addressing critical shortage of supply chain for personal and protective equipment (PPE) arising from Coronavirus disease (COVID19) pandemic ? Case study from the Republic of Ireland |pdf=|usr=}} | ||
+ | |||
+ | |||
*'''[[Educational aspects of the status hygienicus]]''' | *'''[[Educational aspects of the status hygienicus]]''' | ||
Zeile 232: | Zeile 256: | ||
{{tp|p=32300261|t=2020. Severe air pollution events not avoided by reduced anthropogenic activities during COVID-19 outbreak |pdf=|usr=}} | {{tp|p=32300261|t=2020. Severe air pollution events not avoided by reduced anthropogenic activities during COVID-19 outbreak |pdf=|usr=}} | ||
{{tp|p=32333993|t=ä. Does the pathogenesis of SAR-CoV-2 virus decrease at high-altitude?|pdf=|usr=}} | {{tp|p=32333993|t=ä. Does the pathogenesis of SAR-CoV-2 virus decrease at high-altitude?|pdf=|usr=}} | ||
− | + | {{tp|p=32304942|t=2020. Impact of meteorological factors on the COVID-19 transmission: A multi-city study in China |pdf=|usr=}} | |
− | + | {{tp|p=32375105|t=2020. Effect of lockdown amid COVID-19 pandemic on air quality of the megacity Delhi, India |pdf=|usr=}} | |
+ | {{tp|p=32361460|t=2020. Effects of temperature and humidity on the daily new cases and new deaths of COVID-19 in 166 countries |pdf=|usr=}} | ||
+ | {{tp|p=32361428|t=2020. The impact of COVID-19 partial lockdown on the air quality of the city of Rio de Janeiro, Brazil |pdf=|usr=}} | ||
+ | {{tp|p=32361458|t=2020. Sunlight exposure increased Covid-19 recovery rates: A study in the central pandemic area of Indonesia |pdf=|usr=}} | ||
+ | {{tp|p=32353724|t=2020. Association between climate variables and global transmission oF SARS-CoV-2 |pdf=|usr=}} | ||
+ | {{tp|p=32361443|t=2020. Temperature significantly changes COVID-19 transmission in (sub)tropical cities of Brazil |pdf=|usr=}} | ||
+ | {{tp|p=32353722|t=2020. Air quality status during 2020 Malaysia Movement Control Order (MCO) due to 2019 novel coronavirus (2019-nCoV) pandemic |pdf=|usr=}} | ||
+ | {{tp|p=32339844|t=ä. Impact of temperature on the dynamics of the COVID-19 outbreak in China |pdf=|usr=}} | ||
+ | {{tp|p=32361118|t=2020. A spatio-temporal analysis for exploring the effect of temperature on COVID-19 early evolution in Spain |pdf=|usr=}} | ||
+ | {{tp|p=32348946|t=2020. A preliminary assessment of the impact of COVID-19 on environment ? A case study of China |pdf=|usr=}} | ||
+ | {{tp|p=32335409|t=2020. Effect of restricted emissions during COVID-19 on air quality in India |pdf=|usr=}} | ||
+ | {{tp|p=32335408|t=2020. Environmental perspective of COVID-19 |pdf=|usr=}} | ||
+ | {{tp|p=32335407|t=2020. The sensitivity and specificity analyses of ambient temperature and population size on the transmission rate of the novel coronavirus (COVID-19) in different provinces of Iran |pdf=|usr=}} | ||
+ | {{tp|p=32334160|t=2020. Effect of weather on COVID-19 spread in the US: A prediction model for India in 2020 |pdf=|usr=}} | ||
+ | {{tp|p=32334164|t=ä. COVID-19 pandemic and environmental pollution: A blessing in disguise?|pdf=|usr=}} | ||
+ | {{tp|p=32334159|t=ä. Indirect effects of COVID-19 on the environment |pdf=|usr=}} | ||
+ | {{tp|p=32334158|t=ä. Impact of weather on COVID-19 pandemic in Turkey |pdf=|usr=}} | ||
+ | {{tp|p=32334162|t=2020. Correlation between climate indicators and COVID-19 pandemic in New York, USA |pdf=|usr=}} | ||
+ | {{tp|p=32335405|t=2020. COVID-19 transmission in Mainland China is associated with temperature and humidity: A time-series analysis |pdf=|usr=}} | ||
+ | {{tp|p=32361432|t=ä. Investigation of effective climatology parameters on COVID-19 outbreak in Iran |pdf=|usr=}} | ||
+ | {{tp|p=32315907|t=2020. What do we know about the SARS-CoV-2 coronavirus in the environment?|pdf=|usr=}} | ||
+ | {{tp|p=32315904|t=ä. Association between short-term exposure to air pollution and COVID-19 infection: Evidence from China |pdf=|usr=}} | ||
+ | {{tp|p=32302812|t=2020. Assessing nitrogen dioxide (NO2) levels as a contributing factor to coronavirus (COVID-19) fatality |pdf=|usr=}} | ||
+ | {{tp|p=32302810|t=ä. Changes in air quality during the lockdown in Barcelona (Spain) one month into the SARS-CoV-2 epidemic |pdf=|usr=}} | ||
+ | {{tp|p=32269068|t=2020. Susceptibility of ferrets, cats, dogs, and other domesticated animals to SARS?coronavirus 2 |pdf=|usr=}} | ||
*'''[[Origin of Covid19]]''' | *'''[[Origin of Covid19]]''' | ||
Zeile 249: | Zeile 297: | ||
{{tp|p=32296594|t=ä. A systematic approach is needed to contain COVID-19 globally |pdf=|usr=}} | {{tp|p=32296594|t=ä. A systematic approach is needed to contain COVID-19 globally |pdf=|usr=}} | ||
{{tp|p=32210236|t=2020. Epidemiological data from the COVID-19 outbreak, real-time case information |pdf=|usr=}} | {{tp|p=32210236|t=2020. Epidemiological data from the COVID-19 outbreak, real-time case information |pdf=|usr=}} | ||
− | + | {{tp|p=32334207|t=2020. Real-time estimation and prediction of mortality caused by COVID-19 with patient information based algorithm |pdf=|usr=}} | |
+ | {{tp|p=32304973|t=2020. Evaluation of the lockdowns for the SARS-CoV-2 epidemic in Italy and Spain after one month follow up |pdf=|usr=}} | ||
+ | {{tp|p=32283308|t=2020. A field indoor air measurement of SARS-CoV-2 in the patient rooms of the largest hospital in Iran |pdf=|usr=}} | ||
+ | {{tp|p=32361455|t=2020. Modelling spatial variations of coronavirus disease (COVID-19) in Africa |pdf=|usr=}} | ||
+ | {{tp|p=32375067|t=ä. Prediction of the COVID-19 spread in African countries and implications for prevention and controls: A case study in South Africa, Egypt, Algeria, Nigeria, Senegal and Kenya |pdf=|usr=}} | ||
+ | {{tp|p=32361446|t=2020. SutteARIMA: Short-term forecasting method, a case: Covid-19 and stock market in Spain |pdf=|usr=}} | ||
+ | {{tp|p=32371231|t=2020. Computational analysis of SARS-CoV-2/COVID-19 surveillance by wastewater-based epidemiology locally and globally: Feasibility, economy, opportunities and challenges |pdf=|usr=}} | ||
+ | {{tp|p=32336562|t=ä. Restructured society and environment: A review on potential technological strategies to control the COVID-19 pandemic |pdf=|usr=}} | ||
+ | {{tp|p=32339832|t=2020. Inter nation social lockdown versus medical care against COVID-19, a mild environmental insight with special reference to India |pdf=|usr=}} | ||
+ | {{tp|p=32334157|t=ä. Prediction for the spread of COVID-19 in India and effectiveness of preventive measures |pdf=|usr=}} | ||
+ | {{tp|p=32334161|t=2020. Can we predict the occurrence of COVID-19 cases? Considerations using a simple model of growth |pdf=|usr=}} | ||
+ | {{tp|p=32330703|t=2020. Effectiveness of the measures to flatten the epidemic curve of COVID-19 The case of Spain |pdf=|usr=}} | ||
+ | {{tp|p=32371477|t=ä. Rapid implementation of mobile technology for real-time epidemiology of COVID-19 |pdf=|usr=}} | ||
+ | {{tp|p=32234804|t=2020. An investigation of transmission control measures during the first 50 days of the COVID-19 epidemic in China |pdf=|usr=}} | ||
+ | {{tp|p=32234805|t=2020. Quantifying SARS-CoV-2 transmission suggests epidemic control with digital contact tracing |pdf=|usr=}} | ||
+ | {{tp|p=32213647|t=ä. The effect of human mobility and control measures on the COVID-19 epidemic in China |pdf=|usr=}} | ||
+ | {{tp|p=32179701|t=ä. Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV2) |pdf=|usr=}} | ||
+ | {{tp|p=32144116|t=2020. The effect of travel restrictions on the spread of the 2019 novel coronavirus (COVID-19) outbreak |pdf=|usr=}} | ||
+ | {{tp|p=32350060|t=ä. Changes in contact patterns shape the dynamics of the COVID-19 outbreak in China |pdf=|usr=}} | ||
+ | {{tp|p=32269067|t=2020. Effective containment explains subexponential growth in recent confirmed COVID-19 cases in China |pdf=|usr=}} | ||
+ | {{tp|p=32291278|t=ä. Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period |pdf=|usr=}} | ||
Zeile 262: | Zeile 330: | ||
---- | ---- | ||
*'''[[Failure of politics and public health guidance]]''' | *'''[[Failure of politics and public health guidance]]''' | ||
− | + | {{tp|p=C7111621|t=ä. Science Education in the Era of a Pandemic: How Can History, Philosophy and Sociology of Science Contribute to Education for Understanding and Solving the Covid-19 Crisis?|pdf=|usr=}} | |
Zeile 278: | Zeile 346: | ||
*'''[[History of covid19 exploration]]''' | *'''[[History of covid19 exploration]]''' | ||
{{tp|p=32088858|t=ä. Puzzle of highly pathogenic human coronaviruses (2019-nCoV) |pdf=|usr=}} | {{tp|p=32088858|t=ä. Puzzle of highly pathogenic human coronaviruses (2019-nCoV) |pdf=|usr=}} | ||
+ | {{tp|p=32334163|t=2020. Overview of Covid-19; its prevention and management in the light of Unani medicine |pdf=|usr=}} | ||
+ | {{tp|p=32335410|t=2020. COVID-19 outbreak: Migration, effects on society, global environment and prevention |pdf=|usr=}} | ||
+ | |||
Version vom 30. Mai 2020, 08:02 Uhr
32362782 2020. Aktuelle Informationen zu COVID-19 auf einer Plattform ? zeitschriftenübergreifend
32330209 ä. A precision medicine approach to managing 2019 novel coronavirus pneumonia
32278960 2020. COVID-19 from veterinary medicine and one health perspectives: What animal coronaviruses have taught us
32345483 ä. CCOVID-19 with Pulmonary Involvement. An Autoimmune Disease of Known Cause
32334862 ä. COVID-19�: caract�ristiques cliniques, biologiques et radiologiques chez l?adulte, la femme enceinte et l?enfant Une mise au point au c?ur de la pand�mie
32336927 ä. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Emergence, History, Basic and Clinical Aspects
32371230 2020. Evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) as coronavirus disease 2019 (COVID-19) pandemic: A global health emergency
32344226 2020. COVID-19: Disease, management, treatment, and social impact
32327870 ä. Recomendaciones sobre el tratamiento antitromb�tico durante la pandemia COVID-19 Posicionamiento del Grupo de Trabajo de Trombosis Cardiovascular de la Sociedad Espa�ola de Cardiolog�a
C7187661 ä. Group Testing for SARS-CoV-2: Forward to the Past?
32329979 2020. COVID-19 rapid antibody cassette point of care tests: practical considerations
32358057 2020. Overcoming the bottleneck to widespread testing: A rapid review of nucleic acid testing approaches for COVID-19 detection |
32373393 ä. Rapid and Sensitive Detection of COVID-19 Using CRISPR/Cas12a-based Detection with Naked Eye Readout, CRISPR/Cas12a-NER |
32270436 ä. Detection of serum IgM and IgG for COVID-19 diagnosis
32321099 ä. COVID-19 - Computed tomography findings in two patients in Petr�polis, Rio de Janeiro, Brazil
32267461 ä. Chest radiography and computed tomography findings from a Brazilian patient with COVID-19 pneumonia
32215898 2020. CT-Morphologie von COVID-19: Fallbeispiel und Literaturubersicht
32193883 2020. CT appearance of severe, laboratory-proven coronavirus disease 2019 (COVID-19) in a Caucasian patient in Berlin, Germany
32269081 2020. Phylogenetic network analysis of SARS-CoV-2 genomes
32009228 2020. Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission
32277040 2020. Structure of the RNA-dependent RNA polymerase from COVID-19 virus
32075877 2020. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
32165541 2020. Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells
32364961 2020. Severe respiratory SARS-CoV2 infection: Does ACE2 receptor matter?
32245784 2020. A highly conserved cryptic epitope in the receptor binding domains of SARS-CoV-2 and SARS-CoV
32366695 ä. Site-specific glycan analysis of the SARS-CoV-2 spike
32132184 2020. Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2
32291557 ä. SARS-CoV-2-encoded nucleocapsid protein acts as a viral suppressor of RNA interference in cells |
32304647 2020. SARS-CoV-2 shedding and infectivity
32304646 ä. SARS-CoV-2 shedding and infectivity ? Authors reply
32292530 2020. Respiratory diseases, allergy and COVID-19 infection. First news from Wuhan
32326988 ä. Lactose Dehydrogenase in Patients with Severe COVID-19: A Meta-Analysis of Retrospective Study
32339247 ä. Does apolipoprotein E genotype predict COVID-19 severity?
32303993 ä. Recapitulation of SARS-CoV-2 infection and cholangiocyte damage with human liver ductal organoids
32303590 2020. Comparative pathogenesis of COVID-19, MERS, and SARS in a nonhuman primate model
32342879 ä. COVID-19 and radiation induced pneumonitis: overlapping clinical features of different diseases
32222804 ä. Arthralgia as an initial presentation of COVID-19: observation
32192233 2020. Co-infection with SARS-CoV-2 and Human Metapneumovirus
32170625 ä. Co-infections of SARS-CoV-2 with multiple common respiratory pathogens in infected patients
32356640 2020. SARS-CoV-2 pneumonia and pulmonary embolism in a 66-year-old female
32329980 2020. SARS-CoV-2 infection masquerading as a possible pulmonary embolism
32351657 ä. Arterial and venous abdominal thrombosis in a 79-year-old woman with COVID-19 pneumonia
32294340 ä. Immune Thrombocytopenic Purpura in a Patient with Covid-19
32372844 ä. COVID-19 y tratamiento guiado con tests de diagn�stico bioqu�micos y moleculares para reducir el da�o cardiaco y la cardiotoxicidad
32355394 ä. COVID-19 y shock cardiog�nico: diferentes formas de presentaci�n cardiovascular con alta mortalidad
32345547 ä. Fulminant myocarditis due to COVID-19
32267110 2020. COVID-19 et maladies cardiovasculaires
32329044 2020. Complicaciones neurologicas por coronavirus y COVID-19
32359804 ä. Covid-19 and Guillain-Barr� syndrome: More than a coincidence!
32334841 ä. COVID-19 may induce Guillain-Barr� syndrome
32246403 ä. The brain, another potential target organ, needs early protection from SARS-CoV-2 neuroinvasion
32344366 2020. Focal status epilepticus as unique clinical feature of COVID-19: A case report
32328338 2020. Anal swab findings in an infant with COVID?19
32356641 2020. Addressing multiple gastroenterological aspects of COVID-19
32250094 2020. Gastrointestinal symptoms as the first, atypical indication of severe acute respiratory syndrome coronavirus 2 infection
32343593 2020. COVID-19, coronavirus, SARS-CoV-2 and the small bowel
32376072 ä. Beware: Gastrointestinal symptoms can be a manifestation of COVID-19
32353720 2020. COVID-19 faecal-oral transmission: Are we asking the right questions?
32358202 ä. SARS-CoV-2 productively infects human gut enterocytes
32362571 2020. SARS-CoV-2 and the testis: similarity with other viruses and routes of infection
C7129713 ä. Coronavirus: la emergencia geri�trica de 2020 Documento conjunto de la Secci�n de Cardiolog�a Geri�trica de la Sociedad Espa�ola de Cardiolog�a y la Sociedad Espa�ola de Geriatr�a y Gerontolog�a
C7151242 ä. Controversy regarding ACE inhibitors / ARBs in Covid-19
32331829 ä. Smoking and coronavirus disease 2019 (COVID-19)
32362357 ä. Patients with MS treated with immunosuppressive agents: Across the COVID-19 spectrum
32314010 ä. Coronavirus Disease 19 (COVID-19) complicated with pneumonia in a patient with rheumatoid arthritis receiving conventional disease-modifying antirheumatic drugs
32346493 ä. Clinical presentations and outcomes of SARS-CoV-2 infected pneumonia in pregnant women and health status of their neonates
32335406 ä. Factors associated with negative conversion of viral RNA in patients hospitalized with COVID-19
32360909 ä. Follow-up studies in COVID-19 recovered patients - is it mandatory?
32146694 ä. Clinical characteristics of 24 asymptomatic infections with COVID-19 screened among close contacts in Nanjing, China
32048163 2020. Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury |
32239125 2020. Remdesivir, la esperanza antiviral frente al SARS-CoV-2
32256547 2020. Clinical trials on drug repositioning for COVID-19 treatment
32267301 ä. Driving forces for COVID-19 clinical trials using chloroquine: the need to choose the right research questions and outcomes
32232552 ä. Coronavirus disease 2019 (COVID-19) and anti-rheumatic drugs
32124179 ä. Clinical trials for the treatment of Coronavirus disease 2019 (COVID-19): A rapid response to urgent need
32376987 2020. Inhibition of Influenza A virus propagation by benzoselenoxanthenes stabilizing TMPRSS2 Gene G-quadruplex and hence down-regulating TMPRSS2 expression
32278175 ä. COVID-19: A promising cure for the global panic
32253226 ä. (β-D-N4-hydroxycytidine (NHC, EIDD-1931) An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice
32358203 ä. Structural basis for inhibition of the RNA-dependent RNA polymerase from SARS-CoV-2 by remdesivir
32198291 2020. Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved ?-ketoamide inhibitors
32321856 ä. Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease
32291098 ä. Assessing Viral Shedding and Infectivity of Tears in Coronavirus Disease 2019 (COVID-19) Patients
32322159 ä. Electrostatic Charged Nanofiber Filter for Filtering Airborne Novel Coronavirus (COVID-19) and Nano-aerosols |
32372877 2020. Charged PVDF multilayer nanofiber filter in filtering simulated airborne novel coronavirus (COVID-19) using ambient nano-aerosols |
32372843 ä. Telecardiolog�a en tiempos de la pandemia COVID-19
32338017 2020. COVID-19 and the digestive system: protection and management during the SARS-CoV-2 pandemic
32316737 2020. Resumption of activity in gastroenterology departments Recommendations by SEPD, AEEH, GETECCU and AEG
32202911 2020. Recommendations by the SEPD and AEG, both in general and on the operation of gastrointestinal endoscopy and gastroenterology units, concerning the current SARS-CoV-2 pandemic (March, 18)
32329046 2020. Documento EMCAM (Esclerosis Multiple Comunidad Autonoma de Madrid) para el manejo de pacientes con esclerosis multiple durante la pandemia de SARS-CoV-2
32329045 2020. Herramientas de salud digital para superar la brecha de atencion en epilepsia antes, durante y despues de la pandemia de COVID-19
32303331 2020. Covid-19, the pandemic war: Implication for neurologists
32354651 ä. Guidance for the care of neuromuscular patients during the COVID-19 pandemic outbreak from the French Rare Health Care for Neuromuscular Diseases Network
32320999 2020. CHALLENGES IN THE FIGHT AGAINST THE COVID-19 PANDEMIC IN UNIVERSITY HOSPITALS
C7102575 ä. Preventing intra-hospital infection and transmission of COVID-19 in healthcare workers |
32292260 2020. Guidelines for dental care provision during the COVID-19 pandemic
32341229 2020. Saudi association for the study of liver diseases and transplantation position statement on liver transplantation during the COVID-19 pandemic
32343342 ä. The COVID-19 Global Pandemic: Implications for People With Schizophrenia and Related Disorders
32345478 ä. Is schizophrenia research relevant during the COVID-19 pandemic?
32349886 ä. Long-acting injectable antipsychotics treatment during COVID-19 pandemic ? A new challenge
32299718 ä. Ecosystem approaches to the risk for schizophrenia
32327314 ä. COVID-19, mobile health and serious mental illness
32370129 2020. Blockchain-Based Healthcare Workflow for Tele-Medical Laboratory in Federated Hospital IoT Clouds
32283124 ä. Reduction in ST-Segment Elevation Cardiac Catheterization Laboratory Activations in the United States during COVID-19 Pandemic
32242087 ä. What the stock market tells us about the post-COVID-19 world
32313382 ä. Can Global Pharmaceutical Supply Chains Scale Up Sustainably for the COVID-19 Crisis?
32313383 2020. A brave new world: Lessons from the COVID-19 pandemic for transitioning to sustainable supply and production
32304970 2020. Challenges and solutions for addressing critical shortage of supply chain for personal and protective equipment (PPE) arising from Coronavirus disease (COVID19) pandemic ? Case study from the Republic of Ireland
32313309 ä. Education and the COVID-19 pandemic
32302818 2020. Impact Of Sars-Cov-2 And Its Reverberation In Global Higher Education And Mental Health
32300261 2020. Severe air pollution events not avoided by reduced anthropogenic activities during COVID-19 outbreak
32333993 ä. Does the pathogenesis of SAR-CoV-2 virus decrease at high-altitude?
32304942 2020. Impact of meteorological factors on the COVID-19 transmission: A multi-city study in China
32375105 2020. Effect of lockdown amid COVID-19 pandemic on air quality of the megacity Delhi, India
32361460 2020. Effects of temperature and humidity on the daily new cases and new deaths of COVID-19 in 166 countries
32361428 2020. The impact of COVID-19 partial lockdown on the air quality of the city of Rio de Janeiro, Brazil
32361458 2020. Sunlight exposure increased Covid-19 recovery rates: A study in the central pandemic area of Indonesia
32353724 2020. Association between climate variables and global transmission oF SARS-CoV-2
32361443 2020. Temperature significantly changes COVID-19 transmission in (sub)tropical cities of Brazil
32353722 2020. Air quality status during 2020 Malaysia Movement Control Order (MCO) due to 2019 novel coronavirus (2019-nCoV) pandemic
32339844 ä. Impact of temperature on the dynamics of the COVID-19 outbreak in China
32361118 2020. A spatio-temporal analysis for exploring the effect of temperature on COVID-19 early evolution in Spain
32348946 2020. A preliminary assessment of the impact of COVID-19 on environment ? A case study of China
32335409 2020. Effect of restricted emissions during COVID-19 on air quality in India
32335408 2020. Environmental perspective of COVID-19
32335407 2020. The sensitivity and specificity analyses of ambient temperature and population size on the transmission rate of the novel coronavirus (COVID-19) in different provinces of Iran
32334160 2020. Effect of weather on COVID-19 spread in the US: A prediction model for India in 2020
32334164 ä. COVID-19 pandemic and environmental pollution: A blessing in disguise?
32334159 ä. Indirect effects of COVID-19 on the environment
32334158 ä. Impact of weather on COVID-19 pandemic in Turkey
32334162 2020. Correlation between climate indicators and COVID-19 pandemic in New York, USA
32335405 2020. COVID-19 transmission in Mainland China is associated with temperature and humidity: A time-series analysis
32361432 ä. Investigation of effective climatology parameters on COVID-19 outbreak in Iran
32315907 2020. What do we know about the SARS-CoV-2 coronavirus in the environment?
32315904 ä. Association between short-term exposure to air pollution and COVID-19 infection: Evidence from China
32302812 2020. Assessing nitrogen dioxide (NO2) levels as a contributing factor to coronavirus (COVID-19) fatality
32302810 ä. Changes in air quality during the lockdown in Barcelona (Spain) one month into the SARS-CoV-2 epidemic
32269068 2020. Susceptibility of ferrets, cats, dogs, and other domesticated animals to SARS?coronavirus 2
32267109 2020. Coronavirus et COVID-19 : le point sur une pandemie galopante
32294667 ä. Translating transmissibility measures into recommendations for coronavirus prevention
32236385 ä. Outbreak investigation in cargo ship in times of COVID-19 crisis, Port of Santos, Brazil
32320998 ä. COVID-19 in Brazil: advantages of a socialized unified health system and preparation to contain cases
32215461 ä. The value of mitigating epidemic peaks of COVID-19 for more effective public health responses
32296266 ä. Initial impacts of global risk mitigation measures taken during the combatting of the COVID-19 pandemic |
32373394 ä. Using the contact network model and Metropolis-Hastings sampling to reconstruct the COVID-19 spread on the ?Diamond Princess?
32292631 ä. The inflection point about COVID-19 may have passed
32288968 2020. A data driven time-dependent transmission rate for tracking an epidemic: a case study of 2019-nCoV
32296594 ä. A systematic approach is needed to contain COVID-19 globally
32210236 2020. Epidemiological data from the COVID-19 outbreak, real-time case information
32334207 2020. Real-time estimation and prediction of mortality caused by COVID-19 with patient information based algorithm
32304973 2020. Evaluation of the lockdowns for the SARS-CoV-2 epidemic in Italy and Spain after one month follow up
32283308 2020. A field indoor air measurement of SARS-CoV-2 in the patient rooms of the largest hospital in Iran
32361455 2020. Modelling spatial variations of coronavirus disease (COVID-19) in Africa
32375067 ä. Prediction of the COVID-19 spread in African countries and implications for prevention and controls: A case study in South Africa, Egypt, Algeria, Nigeria, Senegal and Kenya
32361446 2020. SutteARIMA: Short-term forecasting method, a case: Covid-19 and stock market in Spain
32371231 2020. Computational analysis of SARS-CoV-2/COVID-19 surveillance by wastewater-based epidemiology locally and globally: Feasibility, economy, opportunities and challenges
32336562 ä. Restructured society and environment: A review on potential technological strategies to control the COVID-19 pandemic
32339832 2020. Inter nation social lockdown versus medical care against COVID-19, a mild environmental insight with special reference to India
32334157 ä. Prediction for the spread of COVID-19 in India and effectiveness of preventive measures
32334161 2020. Can we predict the occurrence of COVID-19 cases? Considerations using a simple model of growth
32330703 2020. Effectiveness of the measures to flatten the epidemic curve of COVID-19 The case of Spain
32371477 ä. Rapid implementation of mobile technology for real-time epidemiology of COVID-19
32234804 2020. An investigation of transmission control measures during the first 50 days of the COVID-19 epidemic in China
32234805 2020. Quantifying SARS-CoV-2 transmission suggests epidemic control with digital contact tracing
32213647 ä. The effect of human mobility and control measures on the COVID-19 epidemic in China
32179701 ä. Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV2)
32144116 2020. The effect of travel restrictions on the spread of the 2019 novel coronavirus (COVID-19) outbreak
32350060 ä. Changes in contact patterns shape the dynamics of the COVID-19 outbreak in China
32269067 2020. Effective containment explains subexponential growth in recent confirmed COVID-19 cases in China
32291278 ä. Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period
32308203 2020. Patients with respiratory symptoms are at greater risk of COVID-19 transmission
C7111621 ä. Science Education in the Era of a Pandemic: How Can History, Philosophy and Sociology of Science Contribute to Education for Understanding and Solving the Covid-19 Crisis?
32203324 ä. COVID-19 and the crisis of national development
32088858 ä. Puzzle of highly pathogenic human coronaviruses (2019-nCoV)
32334163 2020. Overview of Covid-19; its prevention and management in the light of Unani medicine
32335410 2020. COVID-19 outbreak: Migration, effects on society, global environment and prevention
32361911 ä. Single-cell transcriptome analysis of the novel coronavirus (SARS-CoV-2) associated gene ACE2 expression in normal and non-obstructive azoospermia (NOA) human male testes
- from the ads
- [lifechemicals.com antiviral candidate drugs]
- [biomol.com assays cytokines general spectrum]
- [labospace.com custom single probe assay 400 possible cytokines and so on]
- [codexdna.com dna synthesis]
- [eclipsebio.com around rna]
- [btbemulsions.com freud adjuvant kit]
- [biophysics.com div.]
- [molecular-machines.com microdissection]
- Current state of coviki.org